
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A prospective multicenter study of sirolimus for complicated vascular anomalies
Yi Ji, Siyuan Chen, Kaiying Yang, et al.
Journal of Vascular Surgery (2021) Vol. 74, Iss. 5, pp. 1673-1681.e3
Open Access | Times Cited: 43
Yi Ji, Siyuan Chen, Kaiying Yang, et al.
Journal of Vascular Surgery (2021) Vol. 74, Iss. 5, pp. 1673-1681.e3
Open Access | Times Cited: 43
Showing 1-25 of 43 citing articles:
Pathological angiogenesis: mechanisms and therapeutic strategies
Andrew C. Dudley, Arjan W. Griffioen
Angiogenesis (2023) Vol. 26, Iss. 3, pp. 313-347
Open Access | Times Cited: 231
Andrew C. Dudley, Arjan W. Griffioen
Angiogenesis (2023) Vol. 26, Iss. 3, pp. 313-347
Open Access | Times Cited: 231
Sirolimus plus prednisolone vs sirolimus monotherapy for kaposiform hemangioendothelioma: a randomized clinical trial
Yi Ji, Siyuan Chen, Jiangyuan Zhou, et al.
Blood (2022) Vol. 139, Iss. 11, pp. 1619-1630
Open Access | Times Cited: 57
Yi Ji, Siyuan Chen, Jiangyuan Zhou, et al.
Blood (2022) Vol. 139, Iss. 11, pp. 1619-1630
Open Access | Times Cited: 57
Preliminary results of the European multicentric phase III trial regarding sirolimus in slow-flow vascular malformations
Emmanuel Seront, An Van Damme, Catherine Legrand, et al.
JCI Insight (2023) Vol. 8, Iss. 21
Open Access | Times Cited: 25
Emmanuel Seront, An Van Damme, Catherine Legrand, et al.
JCI Insight (2023) Vol. 8, Iss. 21
Open Access | Times Cited: 25
Long‐term outcomes of sirolimus treatment for kaposiform hemangioendothelioma: Continuing successes and ongoing challenges
Jiangyuan Zhou, Yanan Li, Tong Qiu, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 3, pp. 600-608
Closed Access | Times Cited: 14
Jiangyuan Zhou, Yanan Li, Tong Qiu, et al.
International Journal of Cancer (2023) Vol. 153, Iss. 3, pp. 600-608
Closed Access | Times Cited: 14
Targeted Treatments for Vascular Malformations: Current State of the Art.
Emmanuel Seront, Cédric Hermans, Laurence M. Boon, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 11, pp. 2961-2975
Closed Access | Times Cited: 6
Emmanuel Seront, Cédric Hermans, Laurence M. Boon, et al.
Journal of Thrombosis and Haemostasis (2024) Vol. 22, Iss. 11, pp. 2961-2975
Closed Access | Times Cited: 6
Congenital Vascular Malformations in Children: From Historical Perspective to a Multidisciplinary Approach in the Modern Era—A Comprehensive Review
Frederique Bouwman, Bas H. Verhoeven, Willemijn M. Klein, et al.
Children (2024) Vol. 11, Iss. 5, pp. 567-567
Open Access | Times Cited: 5
Frederique Bouwman, Bas H. Verhoeven, Willemijn M. Klein, et al.
Children (2024) Vol. 11, Iss. 5, pp. 567-567
Open Access | Times Cited: 5
Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition
Friedrich Kapp, Farhad Bazgir, Nagi Mahammadzade, et al.
Angiogenesis (2024) Vol. 27, Iss. 4, pp. 739-752
Open Access | Times Cited: 4
Friedrich Kapp, Farhad Bazgir, Nagi Mahammadzade, et al.
Angiogenesis (2024) Vol. 27, Iss. 4, pp. 739-752
Open Access | Times Cited: 4
Consensus statement for the diagnosis, treatment, and prognosis of kaposiform hemangioendothelioma
Jiangyuan Zhou, Tong Qiu, Zixin Zhang, et al.
International Journal of Cancer (2025)
Closed Access
Jiangyuan Zhou, Tong Qiu, Zixin Zhang, et al.
International Journal of Cancer (2025)
Closed Access
A phase 2 randomized, double-blind trial of ART-001, a selective PI3Kα inhibitor, for the treatment of slow-flow vascular malformations
Michio Ozeki, Akira Tanaka, Kanako Kuniyeda, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access
Michio Ozeki, Akira Tanaka, Kanako Kuniyeda, et al.
Orphanet Journal of Rare Diseases (2025) Vol. 20, Iss. 1
Open Access
Targeted Therapies for Slow‐Flow Vascular Malformations
Grace X. Li, Deshan F. Sebaratnam, James P. Pham
Australasian Journal of Dermatology (2025)
Open Access
Grace X. Li, Deshan F. Sebaratnam, James P. Pham
Australasian Journal of Dermatology (2025)
Open Access
Global research trends and basis of venous/lymphatic malformations during 2003–2023: a bibliometric study over two decades
Hongyuan Liu, Junxing Zhu, Hui Chen, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Hongyuan Liu, Junxing Zhu, Hui Chen, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access
Additive Therapeutic Effects of Topical Sirolimus Following Oral Propranolol Therapy for Kaposiform Hemangioendothelioma
Bingyu Xiu, Zigang Xu, Zhe Xu, et al.
Clinical Cosmetic and Investigational Dermatology (2025) Vol. Volume 18, pp. 1261-1267
Open Access
Bingyu Xiu, Zigang Xu, Zhe Xu, et al.
Clinical Cosmetic and Investigational Dermatology (2025) Vol. Volume 18, pp. 1261-1267
Open Access
Safety Evaluation of Oral Sirolimus in the Treatment of Childhood Diseases: A Systematic Review
Zixin Zhang, Yanan Li, Guangyue Zhang, et al.
Children (2022) Vol. 9, Iss. 9, pp. 1295-1295
Open Access | Times Cited: 14
Zixin Zhang, Yanan Li, Guangyue Zhang, et al.
Children (2022) Vol. 9, Iss. 9, pp. 1295-1295
Open Access | Times Cited: 14
Infectious complications of vascular anomalies treated with sirolimus: A systematic review
Rachel Kalbfell, Sally Cohen‐Cutler, Eric Grisham, et al.
Pediatric Blood & Cancer (2023) Vol. 71, Iss. 1
Open Access | Times Cited: 7
Rachel Kalbfell, Sally Cohen‐Cutler, Eric Grisham, et al.
Pediatric Blood & Cancer (2023) Vol. 71, Iss. 1
Open Access | Times Cited: 7
Real-World Data on the Use of Sirolimus in Asian Children with Vascular Malformations
Lu Yu, Zigang Xu, Wei Li, et al.
Pediatric Drugs (2024) Vol. 26, Iss. 3, pp. 309-317
Closed Access | Times Cited: 2
Lu Yu, Zigang Xu, Wei Li, et al.
Pediatric Drugs (2024) Vol. 26, Iss. 3, pp. 309-317
Closed Access | Times Cited: 2
Defining the Role of Oral Pathway Inhibitors as Targeted Therapeutics in Arteriovenous Malformation Care
Ann Mansur, Ivan Radovanovic
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1289-1289
Open Access | Times Cited: 2
Ann Mansur, Ivan Radovanovic
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1289-1289
Open Access | Times Cited: 2
Clinical characteristics and managements of congenital hepatic hemangioma: a cohort study of 211 cases
Xue Gong, Min Yang, Zixin Zhang, et al.
Hepatology International (2024)
Closed Access | Times Cited: 2
Xue Gong, Min Yang, Zixin Zhang, et al.
Hepatology International (2024)
Closed Access | Times Cited: 2
Sirolimus for Pediatric Cervicofacial Lymphatic Malformation: A Systematic Review and Meta‐Analysis
Yasmine Kamhieh, Robin Mitra, Thomas Burnett, et al.
The Laryngoscope (2023) Vol. 134, Iss. 5, pp. 2038-2047
Open Access | Times Cited: 4
Yasmine Kamhieh, Robin Mitra, Thomas Burnett, et al.
The Laryngoscope (2023) Vol. 134, Iss. 5, pp. 2038-2047
Open Access | Times Cited: 4
Oral antibiotic prophylaxis for infection in patients with vascular anomalies receiving sirolimus treatment: a multicenter retrospective study
Tong Qiu, Yanan Li, Xue Gong, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4
Tong Qiu, Yanan Li, Xue Gong, et al.
Orphanet Journal of Rare Diseases (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 4
Successful sirolimus treatment of spindle cell haemangiomas in a paediatric patient with Maffucci syndrome
Rui He, Yanni Wang, Lin Ma, et al.
Clinical and Experimental Dermatology (2024) Vol. 49, Iss. 5, pp. 540-542
Closed Access | Times Cited: 1
Rui He, Yanni Wang, Lin Ma, et al.
Clinical and Experimental Dermatology (2024) Vol. 49, Iss. 5, pp. 540-542
Closed Access | Times Cited: 1
Coexistence of kaposiform hemangioendothelioma and capillary malformation: More than a coincidence? Two case reports
Xue Gong, Jiangyuan Zhou, Siyuan Chen, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28802-e28802
Open Access | Times Cited: 1
Xue Gong, Jiangyuan Zhou, Siyuan Chen, et al.
Heliyon (2024) Vol. 10, Iss. 7, pp. e28802-e28802
Open Access | Times Cited: 1
Management and Outcomes of Pediatric Lymphatic Malformations: A Systematic Review From the APSA Outcomes and Evidence-Based Practice Committee
Carlos Theodore Huerta, Alana L. Beres, Brian R. Englum, et al.
Journal of Pediatric Surgery (2024) Vol. 59, Iss. 10, pp. 161589-161589
Closed Access | Times Cited: 1
Carlos Theodore Huerta, Alana L. Beres, Brian R. Englum, et al.
Journal of Pediatric Surgery (2024) Vol. 59, Iss. 10, pp. 161589-161589
Closed Access | Times Cited: 1
Therapy with sirolimus in vascular anomalies: the experience of two Italian centers on 14 pediatric patients
Alessandro Neirotti, Veronica Barat, Paola Coppo, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 1
Alessandro Neirotti, Veronica Barat, Paola Coppo, et al.
Frontiers in Pediatrics (2024) Vol. 12
Open Access | Times Cited: 1
Sirolimus for kaposiform hemangioendothelioma: Potential mechanisms of action and resistance
Tong Qiu, Shanshan Xiang, Jiangyuan Zhou, et al.
International Journal of Cancer (2024)
Open Access | Times Cited: 1
Tong Qiu, Shanshan Xiang, Jiangyuan Zhou, et al.
International Journal of Cancer (2024)
Open Access | Times Cited: 1
Non-Surgical Management of Recurrent Naso-Orbital Hemangiomas with Bevacizumab: A Case Report
Shengyang Liu, Hui Zhao, Li Shi, et al.
Biologics (2024) Vol. Volume 18, pp. 307-311
Open Access | Times Cited: 1
Shengyang Liu, Hui Zhao, Li Shi, et al.
Biologics (2024) Vol. Volume 18, pp. 307-311
Open Access | Times Cited: 1